Enteral Nutrition Market by Protein Composition (Standard Protein Diet, High Protein Supplement, Protein for Diabetes Care Patient, and Others), Distribution Channel (Hospital Sale, Retail, and Online), and Form & Age Group (Powder and Liquid): Global Opportunity Analysis and Industry Forecast, 2018 - 2025 Update Available On-Demand
|
A04687
|
Pages: 389
|
Sep
2018 |
4203 Views
|
|
|
|
Author(s) :
Shankar Bhandalkar/Tenzin Kunsel/Debojyoti
|
Tables: 297
|
Charts: 50
|
Formats*:
|
|
COVID-19
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Enteral Nutrition Market
Request Now !Enteral Nutrition Market Overview :
The global enteral nutrition market size was valued at $5,661.6 million in 2017, and is projected to reach $10,478.0 million in 2025, registering a CAGR of 7.9% from 2018 to 2025.
Get more information on this report: Request Sample Pages
Enteral nutrition is administration of drugs or food through the gastrointestinal tract using feeding tubes. It is prescribed to patients who are unable to consume food or take sufficient nutrients orally due to difficulty in swallowing or surgery but has a functional gastrointestinal tract. The enteral nutrients are administered directly into the stomach, duodenum, or jejunum of a patient via enteral pumps and enteral feeding tubes generally, in an operation theatre (OT), intensive care unit (ICU), and critical care unit (CCU), and even at home for critically ill patients. Enteral nutrients are prescribed to patients suffering from chronic illness such as malnutrition, gastrointestinal disorder, cancer, and others.
Rise in prevalence of chronic disorders such as cancer and neurological disorders is key factor driving the growth of the enteral nutrition market. In addition, increase in geriatric population and surge in malnutrition cases have fueled the demand for enteral feeding tubes. Over the years, enteral nutrition has been gaining widespread acceptance, owing to enhancement in techniques, configurations, and ingredients. In addition, low cost and complications associated with enteral nutrition supplement the growth of the enteral nutrition market. However, stringent governmental regulations and inadvertent dislodgment of tubes that could lead to accidental disabilities and death have hampered the market growth. Conversely, development of new technologically advanced products and high market potential in untapped emerging economies are expected to provide lucrative opportunities for the market players in future.
Get more information on this report: Request Sample Pages
Enteral nutrition contains macronutrients in the form of isolates of intact proteins, triglycerides, and carbohydrate polymers, which are used for tube feeding to offer complete nutrition. Proteins are required for repairing and maintaining lean body tissues. Protein supplements offer overall, balanced nutrition for long- & short-term tube feeding. Moreover, they help tube-fed patients to gain and maintain normal weight. They are majorly recommended for malnourished, wound healing, and also patients who are susceptible to pressure ulcers. The enteral nutrition market by protein composition is
segmented into standard protein diet, high protein supplement, and protein for diabetes care patient.
Get more information on this report: Request Sample Pages
The number of enteral formulae available for use has dramatically increased over the years, owing to increase in awareness about health & nutrition, cost-effectiveness, and easy availability of enteral nutrition products in the market. Moreover, enteral nutrition products are not labeled as drugs. They are considered as food supplements by the Food and Drug Administration (FDA), which liberalizes the regulatory stringency for these products. On the basis of distribution channel, the market is categorized into hospital sales, retail, and online. Initially, hospital supply and retail were the preferred sources for procuring enteral nutrition products. However, increasing penetration of the internet has increased the demand for online distribution channels in the recent years.
Based on form, the global enteral nutrition market is segregated into powder and liquid. Powdered enteral nutrition is a packaging form in which the enteral formulae comes in solid composition, which needs to be stored in a cool place, away from moisture. The liquid form of enteral nutrition is a ready-to-use, instant feeding formulae, which are available in prefilled ready-to-hang (RTH) containers and cans specifically designed for tube feeding.
North America constituted the highest share in the global enteral feeding devices market, followed by Europe. This is attributed to numerous developments by the key players operating in North America related to enteral nutrition. Asia-Pacific is projected to grow at the highest CAGR, owing to increase in the number of product launches, high demand for enteral nutrition, and increase in awareness toward newly developed enteral feeding & nutrition.
A comprehensive analysis and profiles of major market players, namely Abbott Laboratories, Nestlé S.A., Danone SA, Fresenius Kabi AG, Mead Johnson Nutrition Company, B. Braun Melsungen AG, Global Health Products, Inc., Meiji Holdings Co., Ltd., Victus, Inc., and Hormel Foods Corporation, has been provided in this report.
Key Benefits For Enteral Nutrition Market :
- The report provides an extensive analysis of the current & emerging trends and opportunities in the global enteral nutrition industry.
- A comprehensive analysis of factors that drive and restrict the growth of the market is provided.
- An extensive analysis of the market is conducted by following key product positioning and monitoring the top competitors within the market framework.
- The report provides extensive qualitative insights on the potential and niche segments or regions exhibiting favorable growth.
Enteral Nutrition Key Market Segments :
By Protein Composition
Standard Protein diet
High Protein Supplement
Protein for Diabetes Care Patient
Others
By Distribution Channel
Hospital Sale
Retail
Online
By Form & Age Group
Powder
Age >18 years
Age <18 years
Liquid
Age >18 years
Age <18 years
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
UK
France
Rest of Europe
Asia-Pacific
China
India
Japan
South Korea
Malaysia
Philippines
Myanmar
Vietnam
Rest of Asia-Pacific
CIS
Russia
Kazakhstan
Uzbekistan
Ukraine
Rest of CIS
LAMEA
Brazil
Argentina
Columbia
Kenya
Tanzania
Nigeria
Ethiopia
Saudi Arabia
UAE
Jordan
Rest of LAMEA
CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Porter’s five force analysis
3.4. Top player positioning, 2017
3.5. Market dynamics
3.5.1. Drivers
3.5.1.1. Growth in incidence of chronic diseases
3.5.1.2. Rapid growth in geriatric population
3.5.1.3. Rise in number of malnutrition cases
3.5.1.4. High adoption of enteral nutrition over parenteral nutrition
3.5.2. Restraints
3.5.2.1. Stringent governmental regulations
3.5.2.2. Unintentional dislodgement of tubes leading to critical condition
3.5.3. Opportunities
3.5.3.1. Opportunities in the emerging economies
3.5.3.2. Development of advanced feeding devices with less side effects
3.5.4. Impact analyses
3.6. Dealers in enteral nutrition market, by country
3.7. Analysis of enteral nutrition advertising and campaign
CHAPTER 4: ENTERAL NUTRITION MARKET, BY PROTEIN COMPOSITION
4.1. Overview
4.1.1. Market size and forecast
4.2. Standard protein diet
4.2.1. Key market trends, growth factors, and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market analysis, by country
4.3. High protein supplement
4.3.1. Key market trends, growth factors, and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market analysis, by country
4.4. Protein for diabetes care patient
4.4.1. Key market trends, growth factors, and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market analysis, by country
4.5. Others
4.5.1. Key market trends, growth factors, and opportunities
4.5.2. Market size and forecast, by region
4.5.3. Market analysis, by country
CHAPTER 5: ENTERAL NUTRITION MARKET, BY DISTRIBUTION CHANNEL
5.1. Overview
5.1.1. Market size and forecast
5.2. Hospital sales
5.2.1. Key market trends, growth factors, and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market analysis, by country
5.3. Retail
5.3.1. Key market trends, growth factors, and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market analysis, by country
5.4. Online
5.4.1. Key market trends, growth factors, and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market analysis, by country
CHAPTER 6: ENTERAL NUTRITION MARKET, BY FORM AND AGE GROUP
6.1. Overview
6.1.1. Market size and forecast
6.2. Powder
6.2.1. Key market trends, growth factors, and opportunities
6.2.2. Market size and forecast by age group
6.2.3. Adults (above 18)
6.2.4. Pediatric (below 18)
6.2.5. Market size and forecast, by region
6.2.6. Market analysis, by country
6.3. Liquid
6.3.1. Key market trends, growth factors, and opportunities
6.3.2. Market size and forecast by age group
6.3.3. Adults (above 18)
6.3.4. Pediatric (below 18)
6.3.5. Market size and forecast, by region
6.3.6. Market analysis, by country
CHAPTER 7: ENTERAL NUTRITION MARKET, BY REGION
7.1. Overview
7.1.1. Regulatory analysis for food supplements/dietary supplements/health medical therapy supplement, by country
7.2. North America
7.2.1. Key market trends, growth factors, and opportunities
7.2.2. Market size and forecast, by protein composition
7.2.3. Market size and forecast, by distribution channel
7.2.4. Market size and forecast, by form
7.2.5. Market size and forecast, by country
7.2.6. U.S.
7.2.6.1. Market size and forecast, by protein composition
7.2.6.2. Market size and forecast, by distribution channel
7.2.6.3. Market size and forecast, by form
7.2.7. Canada
7.2.7.1. Market size and forecast, by protein composition
7.2.7.2. Market size and forecast, by distribution channel
7.2.7.3. Market size and forecast, by form
7.2.8. Mexico
7.2.8.1. Market size and forecast, by protein composition
7.2.8.2. Market size and forecast, by distribution channel
7.2.8.3. Market size and forecast, by form
7.3. Europe
7.3.1. Key market trends, growth factors, and opportunities
7.3.2. Market size and forecast, by protein composition
7.3.3. Market size and forecast, by distribution channel
7.3.4. Market size and forecast, by form
7.3.5. Market size and forecast, by country
7.3.6. Germany
7.3.6.1. Market size and forecast, by protein composition
7.3.6.2. Market size and forecast, by distribution channel
7.3.6.3. Market size and forecast, by form
7.3.7. France
7.3.7.1. Market size and forecast, by protein composition
7.3.7.2. Market size and forecast, by distribution channel
7.3.7.3. Market size and forecast, by form
7.3.8. UK
7.3.8.1. Market size and forecast, by protein composition
7.3.8.2. Market size and forecast, by distribution channel
7.3.8.3. Market size and forecast, by form
7.3.9. Rest of Europe
7.3.9.1. Market size and forecast, by protein composition
7.3.9.2. Market size and forecast, by distribution channel
7.3.9.3. Market size and forecast, by form
7.4. Asia-Pacific
7.4.1. Key market trends, growth factors, and opportunities
7.4.2. Market size and forecast, by protein composition
7.4.3. Market size and forecast, by distribution channel
7.4.4. Market size and forecast, by form
7.4.5. Market size and forecast, by country
7.4.6. China
7.4.6.1. Market size and forecast, by protein composition
7.4.6.2. Market size and forecast, by distribution channel
7.4.6.3. Market size and forecast, by form
7.4.7. India
7.4.7.1. Market size and forecast, by protein composition
7.4.7.2. Market size and forecast, by distribution channel
7.4.7.3. Market size and forecast, by form
7.4.8. Japan
7.4.8.1. Market size and forecast, by protein composition
7.4.8.2. Market size and forecast, by distribution channel
7.4.8.3. Market size and forecast, by form
7.4.9. South Korea
7.4.9.1. Market size and forecast, by protein composition
7.4.9.2. Market size and forecast, by distribution channel
7.4.9.3. Market size and forecast, by form
7.4.10. Malaysia
7.4.10.1. Market size and forecast, by protein composition
7.4.10.2. Market size and forecast, by distribution channel
7.4.10.3. Market size and forecast, by form
7.4.11. Philippines
7.4.11.1. Market size and forecast, by protein composition
7.4.11.2. Market size and forecast, by distribution channel
7.4.11.3. Market size and forecast, by form
7.4.12. Myanmar
7.4.12.1. Market size and forecast, by protein composition
7.4.12.2. Market size and forecast, by distribution channel
7.4.12.3. Market size and forecast, by form
7.4.13. Vietnam
7.4.13.1. Market size and forecast, by protein composition
7.4.13.2. Market size and forecast, by distribution channel
7.4.13.3. Market size and forecast, by form
7.4.14. Rest of Asia-Pacific
7.4.14.1. Market size and forecast, by protein composition
7.4.14.2. Market size and forecast, by distribution channel
7.4.14.3. Market size and forecast, by form
7.5. CIS
7.5.1. Key market trends, growth factors, and opportunities
7.5.2. Market size and forecast, by protein composition
7.5.3. Market size and forecast, by distribution channel
7.5.4. Market size and forecast, by form
7.5.5. Market size and forecast, by country
7.5.6. Russia
7.5.6.1. Market size and forecast, by protein composition
7.5.6.2. Market size and forecast, by distribution channel
7.5.6.3. Market size and forecast, by form
7.5.7. Kazakhstan
7.5.7.1. Market size and forecast, by protein composition
7.5.7.2. Market size and forecast, by distribution channel
7.5.7.3. Market size and forecast, by form
7.5.8. Uzbekistan
7.5.8.1. Market size and forecast, by protein composition
7.5.8.2. Market size and forecast, by distribution channel
7.5.8.3. Market size and forecast, by form
7.5.9. Ukraine
7.5.9.1. Market size and forecast, by protein composition
7.5.9.2. Market size and forecast, by distribution channel
7.5.9.3. Market size and forecast, by form
7.5.10. Rest of CIS
7.5.10.1. Market size and forecast, by protein composition
7.5.10.2. Market size and forecast, by distribution channel
7.5.10.3. Market size and forecast, by form
7.6. LAMEA
7.6.1. Key market trends, growth factors, and opportunities
7.6.2. Market size and forecast, by protein composition
7.6.3. Market size and forecast, by distribution channel
7.6.4. Market size and forecast, by form
7.6.5. Market size and forecast, by country
7.6.6. Brazil
7.6.6.1. Market size and forecast, by protein composition
7.6.6.2. Market size and forecast, by distribution channel
7.6.6.3. Market size and forecast, by form
7.6.7. Argentina
7.6.7.1. Market size and forecast, by protein composition
7.6.7.2. Market size and forecast, by distribution channel
7.6.7.3. Market size and forecast, by form
7.6.8. Columbia
7.6.8.1. Market size and forecast, by protein composition
7.6.8.2. Market size and forecast, by distribution channel
7.6.8.3. Market size and forecast, by form
7.6.9. Kenya
7.6.9.1. Market size and forecast, by protein composition
7.6.9.2. Market size and forecast, by distribution channel
7.6.9.3. Market size and forecast, by form
7.6.10. Tanzania
7.6.10.1. Market size and forecast, by protein composition
7.6.10.2. Market size and forecast, by distribution channel
7.6.10.3. Market size and forecast, by form
7.6.11. Nigeria
7.6.11.1. Market size and forecast, by protein composition
7.6.11.2. Market size and forecast, by distribution channel
7.6.11.3. Market size and forecast, by form
7.6.12. Ethiopia
7.6.12.1. Market size and forecast, by protein composition
7.6.12.2. Market size and forecast, by distribution channel
7.6.12.3. Market size and forecast, by form
7.6.13. Saudi Arabia
7.6.13.1. Market size and forecast, by protein composition
7.6.13.2. Market size and forecast, by distribution channel
7.6.13.3. Market size and forecast, by form
7.6.14. UAE
7.6.14.1. Market size and forecast, by protein composition
7.6.14.2. Market size and forecast, by distribution channel
7.6.14.3. Market size and forecast, by form
7.6.15. Jordan
7.6.15.1. Market size and forecast, by protein composition
7.6.15.2. Market size and forecast, by distribution channel
7.6.15.3. Market size and forecast, by form
7.6.16. Rest of LAMEA
7.6.16.1. Market size and forecast, by protein composition
7.6.16.2. Market size and forecast, by distribution channel
7.6.16.3. Market size and forecast, by form
CHAPTER 8: COMPONY PROFILES
8.1. ABBOTT LABORATORIES
8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Operating business segments
8.1.4. Product portfolio
8.1.5. Business performance
8.2. NESTLE S.A
8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Operating business segments
8.2.4. Product portfolio
8.2.5. Business performance
8.2.6. Key strategic moves and developments
8.3. DANONE S.A
8.3.1. Company overview
8.3.2. Company snapshot
8.3.3. Operating business segments
8.3.4. Product portfolio
8.3.5. Business performance
8.4. FRESENIUS KABI AG
8.4.1. Company overview
8.4.2. Company snapshot
8.4.3. Operating business segments
8.4.4. Product portfolio
8.4.5. Business performance
8.4.6. Key strategic moves and developments
8.5. RECKITT BENCKISER GROUP PLC
8.5.1. Company overview
8.5.2. Company snapshot
8.5.3. Operating business segments
8.5.4. Product portfolio
8.5.5. Business performance
8.5.6. Key strategic moves and developments
8.6. B. BRAUN MELSUNGEN AG
8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Product portfolio
8.6.5. Business performance
8.6.6. Key strategic moves and developments
8.7. GLOBAL HEALTH PRODUCTS, INC
8.7.1. Company overview
8.7.2. Company snapshot
8.7.3. Product portfolio
8.7.4. Key strategic moves and developments
8.8. MEIJI HOLDINGS CO., LTD.
8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Product portfolio
8.8.5. Business performance
8.8.6. Key strategic moves and developments
8.9. VICTUS, INC
8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Operating business segments
8.9.4. Product portfolio
8.10. HORMEL FOODS CORPORATION
8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Operating business segments
8.10.4. Product portfolio
8.10.5. Business performance
LIST OF TABLES
TABLE 01. GLOBAL ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 02. GLOBAL ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 03. ENTERAL NUTIRITION MARKET REVENUE FOR STANDARD PROTEIN DIET, BY REGION, 2017–2025 ($MILLION)
TABLE 04. ENTERAL NUTIRITION MARKET VOLUME FOR STANDARD PROTEIN DIET, BY REGION, 2017–2025 (TON)
TABLE 05. ENTERAL NUTIRITION MARKET REVENUE FOR HIGH PROTEIN SUPPLEMENT, BY REGION, 2017–2025 ($MILLION)
TABLE 06. GLOBAL ENTERAL NUTIRITION MARKET VOLUME FOR HIGH PROTEIN SUPPLEMENT, BY REGION, 2017–2025 (TON)
TABLE 07. ENTERAL NUTIRITION MARKET REVENUE FOR PROTEIN FOR DIABETES CARE PATIENT, BY REGION, 2017–2025 ($MILLION)
TABLE 08. ENTERAL NUTIRITION MARKET VOLUME FOR PROTEIN FOR DIABETES CARE PATIENT, BY REGION, 2017–2025 (TON)
TABLE 09. ENTERAL NUTIRITION MARKET REVENUE FOR OTHERS, BY REGION, 2017–2025 ($MILLION)
TABLE 10. ENTERAL NUTIRITION MARKET VOLUME FOR OTHERS, BY REGION, 2017–2025 (TON)
TABLE 11. GLOBAL ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 12. GLOBAL ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 13. ENTERAL NUTIRITION MARKET REVENUE FOR HOSPITAL SALES, BY REGION, 2017–2025 ($MILLION)
TABLE 14. GLOBAL ENTERAL NUTIRITION MARKET VOLUME FOR HOSPITAL SALES, BY REGION, 2017–2025 (TON)
TABLE 15. ENTERAL NUTIRITION MARKET REVENUE FOR RETAIL, BY REGION, 2017–2025 ($MILLION)
TABLE 16. ENTERAL NUTIRITION MARKET VOLUME FOR RETAIL, BY REGION, 2017–2025 (TON)
TABLE 17. ENTERAL NUTIRITION MARKET REVENUE FOR ONLINE, BY REGION, 2017–2025 ($MILLION)
TABLE 18. ENTERAL NUTIRITION MARKET VOLUME FOR ONLINE, BY REGION, 2017–2025 (TON)
TABLE 19. GLOBAL ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 20. GLOBAL ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 21. GLOBAL POWDER ENTERAL NUTRITION MARKET REVENUE, BY AGE GROUP, 2017–2025 ($MILLION)
TABLE 22. GLOBAL POWDER ENTERAL NUTRITION MARKET VOLUME, BY AGE GROUP, 2017–2025 (TON)
TABLE 23. ENTERAL NUTIRITION MARKET REVENUE FOR POWDER, BY REGION, 2017–2025 ($MILLION)
TABLE 24. ENTERAL NUTIRITION MARKET VOLUME FOR POWDER, BY REGION, 2017–2025 (TON)
TABLE 25. GLOBAL LIQUID ENTERAL NUTRITION MARKET REVENUE, BY AGE GROUP, 2017–2025 ($MILLION)
TABLE 26. GLOBAL LIQUID ENTERAL NUTRITION MARKET VOLUME, BY AGE GROUP, 2017–2025 (TON)
TABLE 27. ENTERAL NUTIRITION MARKET REVENUE FOR LIQUID, BY REGION, 2017–2025 ($MILLION)
TABLE 28. ENTERAL NUTIRITION MARKET VOLUME FOR LIQUID, BY REGION, 2017–2025 (TON)
TABLE 29. ENTERAL NUTRITION MARKET REVENUE, BY REGION, 2017–2025 ($MILLION)
TABLE 30. ENTERAL NUTRITION MARKET VOLUME, BY REGION, 2017–2025 (TON)
TABLE 31. NORTH AMERICA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 32. NORTH AMERICA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 33. NORTH AMERICA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 34. NORTH AMERICA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 35. NORTH AMERICA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 36. NORTH AMERICA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 37. NORTH AMERICA ENTERAL NUTRITION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 38. NORTH AMERICA ENTERAL NUTRITION MARKET VOLUME, BY COUNTRY, 2017–2025 (TON)
TABLE 39. U.S. ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 40. U.S. ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 41. U.S. ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 42. U.S. ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 43. U.S. ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 44. U.S. ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 45. CANADA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 46. CANADA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 47. CANADA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 48. CANADA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 49. CANADA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 50. CANADA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 51. MEXICO ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 52. MEXICO ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 53. MEXICO ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 54. MEXICO ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 55. MEXICO ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 56. MEXICO ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 57. EUROPE ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 58. EUROPE ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 59. EUROPE ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 60. EUROPE ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 61. EUROPE ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 62. EUROPE ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 63. EUROPE ENTERAL NUTRITION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 64. EUROPE ENTERAL NUTRITION MARKET VOLUME, BY COUNTRY, 2017–2025 (TON)
TABLE 65. GERMANY ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 66. GERMANY ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 67. GERMANY ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 68. GERMANY ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 69. GERMANY ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 70. GERMANY ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 71. FRANCE ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 72. FRANCE ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 73. FRANCE ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 74. FRANCE ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 75. FRANCE ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 76. FRANCE ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 77. UK ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 78. UK ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 79. UK ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 80. UK ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 81. UK ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 82. UK ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 83. REST OF EUROPE ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 84. REST OF EUROPE ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 85. REST OF EUROPE ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 86. REST OF EUROPE ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 87. REST OF EUROPE ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 88. REST OF EUROPE ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 89. ASIA-PACIFIC ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 90. ASIA-PACIFIC ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 91. ASIA-PACIFIC ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 92. ASIA-PACIFIC ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 93. ASIA-PACIFIC ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 94. ASIA-PACIFIC ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 95. ASIA-PACIFIC ENTERAL NUTRITION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 96. ASIA-PACIFIC ENTERAL NUTRITION MARKET VOLUME, BY COUNTRY, 2017–2025 (TON)
TABLE 97. CHINA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 98. CHINA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 99. CHINA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 100. CHINA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 101. CHINA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 102. CHINA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 103. INDIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 104. INDIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 105. INDIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 106. INDIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 107. INDIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 108. INDIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 109. JAPAN ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 110. JAPAN ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 111. JAPAN ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 112. JAPAN ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 113. JAPAN ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 114. JAPAN ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 115. SOUTH KOREA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 116. SOUTH KOREA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 117. SOUTH KOREA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 118. SOUTH KOREA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 119. SOUTH KOREA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 120. SOUTH KOREA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 121. MALAYSIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 122. MALAYSIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 123. MALAYSIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 124. MALAYSIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 125. MALAYSIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 126. MALAYSIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 127. PHILIPPINES ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 128. PHILIPPINES ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 129. PHILIPPINES ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 130. PHILIPPINES ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 131. PHILIPPINES ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 132. PHILIPPINES ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 133. MYANMAR ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 134. MYANMAR ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 135. MYANMAR ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 136. MYANMAR ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 137. MYANMAR ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 138. MYANMAR ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 139. VIETNAM ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 140. VIETNAM ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 141. VIETNAM ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 142. VIETNAM ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 143. VIETNAM ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 144. VIETNAM ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 145. REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 146. REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 147. REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 148. REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 149. REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 150. REST OF ASIA-PACIFIC ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 151. CIS ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 152. CIS ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 153. CIS ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 154. CIS ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 155. CIS ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 156. CIS ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 157. CIS ENTERAL NUTRITION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 158. CIS ENTERAL NUTRITION MARKET VOLUME, BY COUNTRY, 2017–2025 (TON)
TABLE 159. RUSSIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 160. RUSSIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 161. RUSSIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 162. RUSSIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 163. RUSSIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 164. RUSSIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 165. KAZAKHSTAN ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 166. KAZAKHSTAN ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 167. KAZAKHSTAN ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 168. KAZAKHSTAN ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 169. KAZAKHSTAN ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 170. KAZAKHSTAN ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 171. UZBEKISTAN ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 172. UZBEKISTAN ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 173. UZBEKISTAN ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 174. UZBEKISTAN ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 175. UZBEKISTAN ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 176. UZBEKISTAN ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 177. UKRAINE ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 178. UKRAINE ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 179. UKRAINE ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 180. UKRAINE ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 181. UKRAINE ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 182. UKRAINE ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 183. REST OF CIS ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 184. REST OF CIS ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 185. REST OF CIS ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 186. REST OF CIS ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 187. REST OF CIS ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 188. REST OF CIS ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 189. LAMEA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 190. LAMEA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 191. LAMEA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 192. LAMEA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 193. LAMEA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 194. LAMEA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 195. LAMEA ENTERAL NUTRITION MARKET REVENUE, BY COUNTRY, 2017–2025 ($MILLION)
TABLE 196. LAMEA ENTERAL NUTRITION MARKET VOLUME, BY COUNTRY, 2017–2025 (TON)
TABLE 197. BRAZIL ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 198. BRAZIL ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 199. BRAZIL ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 200. BRAZIL ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 201. BRAZIL ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 202. BRAZIL ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 203. ARGENTINA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 204. ARGENTINA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 205. ARGENTINA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 206. ARGENTINA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 207. ARGENTINA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 208. ARGENTINA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 209. COLUMBIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 210. COLUMBIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 211. COLUMBIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 212. COLUMBIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 213. COLUMBIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 214. COLUMBIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 215. KENYA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 216. KENYA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 217. KENYA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 218. KENYA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 219. KENYA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 220. KENYA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 221. TANZANIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 222. TANZANIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 223. TANZANIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 224. TANZANIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 225. TANZANIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 226. TANZANIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 227. NIGERIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 228. NIGERIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 229. NIGERIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 230. NIGERIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 231. NIGERIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 232. NIGERIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 233. ETHIOPIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 234. ETHIOPIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 235. ETHIOPIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 236. ETHIOPIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 237. ETHIOPIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 238. ETHIOPIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 239. SAUDI ARABIA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 240. SAUDI ARABIA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 241. SAUDI ARABIA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 242. SAUDI ARABIA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 243. SAUDI ARABIA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 244. SAUDI ARABIA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 245. UAE ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 246. UAE ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 247. UAE ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 248. UAE ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 249. UAE ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 250. UAE ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 251. JORDAN ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 252. JORDAN ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 253. JORDAN ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 254. JORDAN ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 255. JORDAN ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 256. JORDAN ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 257. REST OF LAMEA ENTERAL NUTRITION MARKET REVENUE, BY PROTEIN COMPOSITION, 2017–2025 ($MILLION)
TABLE 258. REST OF LAMEA ENTERAL NUTRITION MARKET VOLUME, BY PROTEIN COMPOSITION, 2017–2025 (TON)
TABLE 259. REST OF LAMEA ENTERAL NUTRITION MARKET REVENUE, BY DISTRIBUTION CHANNEL, 2017–2025 ($MILLION)
TABLE 260. REST OF LAMEA ENTERAL NUTRITION MARKET VOLUME, BY DISTRIBUTION CHANNEL, 2017–2025 (TON)
TABLE 261. REST OF LAMEA ENTERAL NUTRITION MARKET REVENUE, BY FORM, 2017–2025 ($MILLION)
TABLE 262. REST OF LAMEA ENTERAL NUTRITION MARKET VOLUME, BY FORM, 2017–2025 (TON)
TABLE 263. ABBOTT LABORATORIES: COMPANY SNAPSHOT
TABLE 264. ABBOTT LABORATORIES: OPERATING SEGMENTS
TABLE 265. ABBOTT LABORATORIES: PRODUCT PORTFOLIO
TABLE 266. NESTLE S.A: COMPANY SNAPSHOT
TABLE 267. NESTLE S.A: OPERATING SEGMENTS
TABLE 268. NESTLE S.A: PRODUCT PORTFOLIO
TABLE 269. NESTLE S.A: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 270. DANONE S.A: COMPANY SNAPSHOT
TABLE 271. DANONE S.A: OPERATING SEGMENTS
TABLE 272. DANONE S.A: PRODUCT PORTFOLIO
TABLE 273. FRESENIUS KABI AG: COMPANY SNAPSHOT
TABLE 274. FRESENIUS KABI AG: OPERATING SEGMENTS
TABLE 275. FRESENIUS KABI AG: PRODUCT PORTFOLIO
TABLE 276. FRESENIUS KABI AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 277. RECKITT BENCKISER GROUP PLC: COMPANY SNAPSHOT
TABLE 278. RECKITT BENCKISER GROUP PLC: OPERATING SEGMENTS
TABLE 279. RECKITT BENCKISER GROUP PLC: PRODUCT PORTFOLIO
TABLE 280. RECKITT BENCKISER GROUP PLC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 281. B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
TABLE 282. B. BRAUN MELSUNGEN AG: OPERATING SEGMENTS
TABLE 283. B. BRAUN MELSUNGEN AG: PRODUCT PORTFOLIO
TABLE 284. B. BRAUN MELSUNGEN AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 285. GLOBAL HEALTH PRODUCTS, INC: COMPANY SNAPSHOT
TABLE 286. GLOBAL HEALTH PRODUCTS, INC: PRODUCT PORTFOLIO
TABLE 287. GLOBAL HEALTH PRODUCTS, INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 288. MEIJI HOLDINGS CO., LTD.: COMPANY SNAPSHOT
TABLE 289. MEIJI HOLDINGS CO., LTD.: OPERATING SEGMENTS
TABLE 290. MEIJI HOLDINGS CO., LTD.: PRODUCT PORTFOLIO
TABLE 291. MEIJI HOLDINGS CO., LTD.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 292. VICTUS, INC: COMPANY SNAPSHOT
TABLE 293. VICTUS, INC: OPERATING SEGMENTS
TABLE 294. VICTUS, INC: PRODUCT PORTFOLIO
TABLE 295. HORMEL FOODS CORPORATION: COMPANY SNAPSHOT
TABLE 296. HORMEL FOODS CORPORATION: OPERATING SEGMENTS
TABLE 297. HORMEL FOODS CORPORATION: PRODUCT PORTFOLIO
LIST OF FIGURES
FIGURE 01. GLOBAL ENTERAL NUTRITION MARKET SNAPSHOT
FIGURE 02. ENTERAL NUTRITION MARKET SEGMENTATION
FIGURE 03. TOP INVESTMENT POCKETS
FIGURE 04. TOP WINNING STRATEGIES, BY YEAR, 2015–2018*
FIGURE 05. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2015–2018* (%)
FIGURE 06. TOP WINNING STRATEGIES, BY COMPANY, 2015–2018*
FIGURE 07. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08. LOW BARGAINING POWER OF BUYERS
FIGURE 09. LOW THREAT OF NEW ENTRANTS
FIGURE 10. MODERATE THREAT OF SUBSTITUTION
FIGURE 11. MODERATE INTENSITY OF COMPETITIVE RIVALRY
FIGURE 12. TOP PLAYER POSITIONING, 2017
FIGURE 13. ENTERAL NUTRITION MARKET: DRIVERS, RESTRAINTS, AND OPPORTUNITIES, 2018 2025
FIGURE 14. NUMBER OF NEW CASES OF CANCER PER 100,000 PEOPLE, 2018
FIGURE 15. ELDERLY POPULATION PERCANTAGE (65 YEARS AND OVER) BY COUNTRY, 2014 (%)
FIGURE 16. POPULATION AGED 60 YEARS OR OVER BY REGION, 2000-2050 (MILLION)
FIGURE 17. PERCENTAGE OF UNDERNOURISHED PEOPLE BY REGION, 2013
FIGURE 18. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR STANDARD PROTEIN DIET, 2017 & 2025 (%)
FIGURE 19. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR HIGH PROTEIN SUPPLEMENT, 2017 & 2025 (%)
FIGURE 20. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR DIABETES CARE PATIENT, 2017 & 2025 (%)
FIGURE 21. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR OTHERS, 2017 & 2025 (%)
FIGURE 22. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR HOSPITAL SALES, 2017 & 2025 (%)
FIGURE 23. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR RETAIL, 2017 & 2025 (%)
FIGURE 24. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR ONLINE, 2017 & 2025 (%)
FIGURE 25. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR POWDER, 2017 & 2025 (%)
FIGURE 26. COMPARATIVE ANALYSIS OF ENTERAL NUTRITION MARKET REVENUE FOR LIQUID, 2017 & 2025 (%)
FIGURE 27. PROPORTIONAL MORTALITY (% OF TOTAL DEATHS, ALL AGES) IN RUSSIA, 2015 (%)
FIGURE 28. ABBOTT LABORATORIES: REVENUE, 2015–2017 ($MILLION)
FIGURE 29. ABBOTT LABORATORIES: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 30. ABBOTT LABORATORIES: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 31. NESTLE S.A: REVENUE, 2015–2017 ($MILLION)
FIGURE 32. NESTLE S.A: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 33. NESTLE S.A: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 34. DANONE S.A: REVENUE, 2015–2017 ($MILLION)
FIGURE 35. DANONE S.A: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 36. DANONE S.A: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 37. FRESENIUS KABI AG: REVENUE, 2015–2017 ($MILLION)
FIGURE 38. FRESENIUS KABI AG: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 39. FRESENIUS KABI AG: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 40. RECKITT BENCKISER GROUP PLC: REVENUE, 2015–2017 ($MILLION)
FIGURE 41. RECKITT BENCKISER GROUP PLC: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 42. RECKITT BENCKISER GROUP PLC: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 43. B. BRAUN MELSUNGEN AG: REVENUE, 2015–2017 ($MILLION)
FIGURE 44. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 45. B. BRAUN MELSUNGEN AG: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
FIGURE 46. MEIJI HOLDINGS CO., LTD.: REVENUE, 2015–2017 ($MILLION)
FIGURE 47. MEIJI HOLDINGS CO., LTD.: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 48. HORMEL FOODS CORPORATION: REVENUE, 2015–2017 ($MILLION)
FIGURE 49. HORMEL FOODS CORPORATION: REVENUE SHARE BY SEGMENT, 2017 (%)
FIGURE 50. HORMEL FOODS CORPORATION: REVENUE SHARE BY GEOGRAPHY, 2017 (%)
The North America ethanolamine market witnessed significant growth in the recent years owing to rise in surfactant requirement and growth in the demand for crop protection chemicals among farmers in North America. Fluctuating prices of raw materials that are used for ethanolamine production is a major constraint for the North America ethanolamine market.
Increase in demand for ethanolamine in cosmetics and other end-user industries fuels the market growth. The demand for ethanolamine in Canada and Mexico cosmetic industries has increased considerably in the last decade. Major cosmetic manufacturers such as L'Oréal, Avon, and Proctor & Gamble, have been using ethanolamine in their products, which contributes significantly toward the growth of the North America ethanolamine market. Moreover, governments in North America have been promoting the use of bio-surfactants, which is further anticipated to boost the North America ethanolamine market.
Download Sample
Purchase Full Report of
Enteral Nutrition Market
- Online Only
- $3,539
- Online cloud access only
- Restricted print, copy, paste & download
- Read only
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Data Pack
- $3,933
- Restricted to one authorized user
- One print only
- Available in
Excel - Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Single User
- $5,899
- Restricted to one authorized user
- One print only
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Five Users
- $6,606
- Limited to five authorized users
- Print upto five copies
- Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
-
Enterprise
License/PDF - $9,213
- Unlimited
within
company/enterprise - Available in Excel & PDF
- Free quarterly industry update
- Free report update (Within 180 days)
- Subscription model sign in
- Library Membership
- $0.00
- Published Content
E-access - Company Profiles
E-access - Newly Added Content Access
- 10 PDF
Downloads - 5 Excel Data
Pack Downloads - 250 Company Profiles PDF Downloads
-
Start reading instantly.
Buy Now
This title and over 12,000+ are available on the Avenue Library. Subscription @ $699 T&C*.
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
Why Allied Market Research?
Infallible Methodology
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
Analyst Support
For complete satisfaction
Customization
On-demand customization of scope of the report to exactly meet your needs
TARGETED MARKET VIEW
Targeted market view to provide pertinent information and save time of readers
Get fresh content delivered
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.